EDGAR Filing Documents for 0001104659-17-003924

Form 8-K - Current report:

SEC Accession No. 0001104659-17-003924

Filing Date

2017-01-25

Accepted

2017-01-25 08:00:35

Documents

Period of Report

2017-01-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a17-3141_18k.htm	8-K	24584
2	EX-99.1	a17-3141_1ex99d1.htm	EX-99.1	16547
3	GRAPHIC	g31411mmi001.gif	GRAPHIC	3754
	Complete submission text file	0001104659-17-003924.txt		47727

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 17545019
SIC: 2834 Pharmaceutical Preparations